Decoding protein MARylation networks in astrocytes using chemical biology approaches

使用化学生物学方法解码星形胶质细胞中的蛋白质 MARylation 网络

基本信息

  • 批准号:
    10378049
  • 负责人:
  • 金额:
    $ 50.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-15 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary Astrocytes are critical regulators of innate immunity in the central nervous system (CNS). Stimulation of CNS innate immunity by neuroinflammatory activators such as pathogens and brain injury, as well as in response to neurodegeneration, cause astrocytes to undergo a transition to a reactive phenotype called astrogliosis. While it is well accepted that astrogliosis can act as a protective mechanism to minimize CNS damage, the mechanisms that regulate astrogliosis are not well understood. Our preliminary results and data from the literature support our general hypothesis that PARP7 controlled MARylation critically shapes the innate immune responses in the CNS. Our long-term goal is to understand the role of PARP7 in astrogliosis and whether PARP7 represents an actionable target for CNS pathologies that arise as a consequence of activation of CNS innate immunity. The objective of the proposed work is elucidate the mechanisms by which PARP7 regulates innate immunity in astrocytes. PARP7 has emerged as a critically important member of a large enzyme family known as PARPs, especially in the innate immune response. Similar to other PARP family members, PARP7 catalyzes the post- translational modification known as mono-ADP-ribosylation (MARylation), which involves the transfer of ADP-ribose from NAD+ to amino acids on target proteins. The MARylation targets of PARP7 in astrocytes are unknown. To decode the mechanisms by which PARP7 regulates innate immunity in astrocyte, we need to identify the direct targets of PARP7 in astrocytes. Identifying the direct targets of PARP7 has been challenging, however, due to the fact that PARPs share the same substrate NAD+. To overcome this limitation, we describe the development of engineered PARP7—orthogonal NAD+ analogue pairs for identifying the direct targets of PARP7 in astrocytes lysates (Aim I). We also describe the generation of membrane-permeant variants of our orthogonal NAD+ analogues, which are critical for identifying PARP7 targets in intact astrocytes using stimuli that activate the innate immune response in astrocytes (Aim II). Lastly, we describe a strategy for improving the selectivity of PARP7 inhibitors (Aim III). Selective inhibitors of PARP7 are essential chemical probes for evaluating the function of PARP7-mediated MARylation in the innate immune response in astrocytes. We anticipate that these studies will not only clarify our understanding of the function of PARP7-mediated MARylation in innate immunity in astrocytes, but could also lead to new therapeutic strategies for CNS pathologies, particularly neuroinflammatory (e.g. multiple sclerosis) and neurodegenerative diseases (e.g. Alzheimer's disease). More generally, the results obtained from these studies will have far-reaching impact on our understanding of MARylation in cell signaling.
项目摘要 星形胶质细胞是中枢神经系统(CNS)先天免疫的关键调节因子。刺激CNS 病原体和脑损伤等神经炎症激活剂的先天免疫,以及对 神经变性导致星形胶质细胞转变为称为星形胶质细胞增生的反应性表型。虽然 星形胶质细胞增生可以作为一种保护机制,以尽量减少中枢神经系统的损害,这种机制是公认的, 调节星形胶质细胞增生的机制还不清楚。我们的初步结果和文献数据支持 我们的一般假设是PARP 7控制的MARylation关键地塑造了先天性免疫应答, CNS。我们的长期目标是了解PARP 7在星形胶质细胞增生中的作用,以及PARP 7是否代表星形胶质细胞增生。 作为CNS先天免疫激活的结果而出现的CNS病理的可作用靶标。的 这项工作的目的是阐明PARP 7调节先天免疫的机制, 星形胶质细胞PARP 7已经成为称为PARP的大酶家族中至关重要的成员, 尤其是先天免疫反应。与其他PARP家族成员相似,PARP 7催化后 翻译修饰称为单ADP核糖基化(MARylation),它涉及转移 ADP-核糖从NAD+到靶蛋白上的氨基酸。星形胶质细胞中PARP 7的MARylation靶标是 未知为了解码PARP 7调节星形胶质细胞先天免疫的机制,我们需要 识别星形胶质细胞中PARP 7的直接靶点。识别PARP 7的直接靶点一直具有挑战性, 然而,由于PARP共享相同底物NAD+的事实。为了克服这一限制,我们描述 开发工程化PARP 7-正交NAD+类似物对,用于鉴定 星形胶质细胞裂解物中的PARP 7(Aim I)。我们还描述了我们的膜渗透变体的产生。 正交NAD+类似物,其对于使用刺激物鉴定完整星形胶质细胞中的PARP 7靶标至关重要 激活星形胶质细胞中的先天免疫反应(Aim II)。最后,我们描述了一种改进的策略, PARP 7抑制剂的选择性(目的III)。PARP 7的选择性抑制剂是用于治疗糖尿病的重要化学探针。 评估PARP 7介导的MARylation在星形胶质细胞先天免疫应答中的功能。我们 预计这些研究不仅将澄清我们对PARP 7介导的功能的理解, MARylation在星形胶质细胞先天免疫中的作用,但也可能导致CNS疾病的新治疗策略。 病理学,特别是神经炎性(例如多发性硬化)和神经变性疾病(例如, 阿尔茨海默病)。更广泛地说,这些研究的结果将对我们的 了解细胞信号中的MARylation。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael S Cohen其他文献

The significance of mast cells in basal cell carcinoma.
肥大细胞在基底细胞癌中的意义。
NON-CLAMPED, NON-ISCHEMIC PARTIAL NEPHRECTOMY: THE NEW GOLD STANDARD
  • DOI:
    10.1016/s0022-5347(08)61400-7
  • 发表时间:
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Teodora Kurteva;Michael S Cohen;Gjanje L Smith;John A Libertino
  • 通讯作者:
    John A Libertino
THE QUEST TO FIND HIGH GRADE PROSTATE CANCER: ARE WE FAILING?
  • DOI:
    10.1016/s0022-5347(08)60430-9
  • 发表时间:
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sarah Fitch;Michael S Cohen;Robin Ruthazer;John A Libertino
  • 通讯作者:
    John A Libertino
AI Model Versus Clinician Otoscopy in the Operative Setting for Otitis Media Diagnosis.
AI 模型与临床医生耳镜检查在中耳炎诊断手术中的比较。
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Krish Suresh;Michael P Wu;Fouzi Benboujja;Barbara Christakis;Alice Newton;Christopher J. Hartnick;Michael S Cohen
  • 通讯作者:
    Michael S Cohen
Reward enhancement of item-location associative memory spreads to similar items within a category.
项目位置关联记忆的奖励增强会扩散到类别内的相似项目。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Evan Grandoit;Michael S Cohen;Paul J. Reber
  • 通讯作者:
    Paul J. Reber

Michael S Cohen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael S Cohen', 18)}}的其他基金

Identifying the molecular target for macrophage activation by chlorpyrifos
确定毒死蜱激活巨噬细胞的分子靶标
  • 批准号:
    10555298
  • 财政年份:
    2022
  • 资助金额:
    $ 50.3万
  • 项目类别:
Identifying the targets of virus-induced PARPs during SARS-CoV-2 infection
识别 SARS-CoV-2 感染期间病毒诱导的 PARP 的靶标
  • 批准号:
    10573499
  • 财政年份:
    2022
  • 资助金额:
    $ 50.3万
  • 项目类别:
Identifying the molecular target for macrophage activation by chlorpyrifos
确定毒死蜱激活巨噬细胞的分子靶标
  • 批准号:
    10467360
  • 财政年份:
    2022
  • 资助金额:
    $ 50.3万
  • 项目类别:
Decoding protein MARylation networks in astrocytes using chemical biology approaches
使用化学生物学方法解码星形胶质细胞中的蛋白质 MARylation 网络
  • 批准号:
    10599222
  • 财政年份:
    2014
  • 资助金额:
    $ 50.3万
  • 项目类别:
Decoding protein ADP-ribosylation networks in neurons using a chemical genetic ap
使用化学遗传 ap 解码神经元中的蛋白质 ADP-核糖基化网络
  • 批准号:
    9272745
  • 财政年份:
    2014
  • 资助金额:
    $ 50.3万
  • 项目类别:
Decoding protein ADP-ribosylation networks in neurons using a chemical genetic ap
使用化学遗传 ap 解码神经元中的蛋白质 ADP-核糖基化网络
  • 批准号:
    8765046
  • 财政年份:
    2014
  • 资助金额:
    $ 50.3万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.3万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了